{"id":{"repo_id":"usf","oai_identifier":"oai:digitalcommons.usf.edu:etd-12715"},"canonical_url":"https://search.ndltd.org/etd/usf/oai:digitalcommons.usf.edu:etd-12715","repository":{"repo_id":"usf","name":"University of South Florida","base_url":"https://digitalcommons.usf.edu/do/oai/"},"display":{"title":"Dual-Modal Tumor Imaging Using Functionalized Iron-Oxide Nanoparticles for MRI and Fluorescence","abstract":"Accurate tumor imaging is essential for early cancer detection and treatment monitoring [1]. Technetium-99m (Tc-99m) is a commonly used radioisotope for medical imaging, but its reliance on gamma-ray emission poses challenges related to safety, accessibility, and regulatory constraints[2-5]. This research proposes the development of a dual-modal imaging approach by functionalizing iron-oxide nanoparticles (IONPs) with the fluorescent chromophore Cy5, enabling both MRI contrast enhancement and optical imaging for improved tumor specificity. IONPs provide strong T2-weighted MRI contrast [6], while conjugated near-infrared (NIR) chromophores allow for high-resolution fluorescence imaging [7], making this proposed system adaptable for both in vitro and in vivo applications. Additionally, functionalization with cancer-specific ligands, such as folic acid (FA), enables targeted delivery of the nanoparticle (NP) to tumor cells that overexpress folate receptors (FRs) which are minimally present in healthy tissues [8, 9]. The nanoparticle’s efficacy will be evaluated through in vitro studies with the goal of offering an improved alternative for accurate cancer diagnosis. This multi-modal imaging platform offers a non-radioactive, cost-effective alternative to nuclear medicine tracers, with potential applications in precision cancer diagnostics.","abstract_html":"Accurate tumor imaging is essential for early cancer detection and treatment monitoring [1]. Technetium-99m (Tc-99m) is a commonly used radioisotope for medical imaging, but its reliance on gamma-ray emission poses challenges related to safety, accessibility, and regulatory constraints[2-5]. This research proposes the development of a dual-modal imaging approach by functionalizing iron-oxide nanoparticles (IONPs) with the fluorescent chromophore Cy5, enabling both MRI contrast enhancement and optical imaging for improved tumor specificity. IONPs provide strong T2-weighted MRI contrast [6], while conjugated near-infrared (NIR) chromophores allow for high-resolution fluorescence imaging [7], making this proposed system adaptable for both in vitro and in vivo applications. Additionally, functionalization with cancer-specific ligands, such as folic acid (FA), enables targeted delivery of the nanoparticle (NP) to tumor cells that overexpress folate receptors (FRs) which are minimally present in healthy tissues [8, 9]. The nanoparticle’s efficacy will be evaluated through in vitro studies with the goal of offering an improved alternative for accurate cancer diagnosis. This multi-modal imaging platform offers a non-radioactive, cost-effective alternative to nuclear medicine tracers, with potential applications in precision cancer diagnostics.","abstract_has_math":false,"creators":["Secades, Kevin"],"institution":"University of South Florida","degree_name":"Master of Science (M.S.)","degree_level":"Thesis","degree_discipline":"Pharmacy","degree_department":null,"school":null,"contributors":["Diane S. Allen-Gipson, Ph.D.","Mikalai Budzevich, Ph.D.","Ashok Kumar, Ph.D.","Stephanie Zhou, Ph.D."],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2026,"date_issued":"2026-03-11T07:00:00Z","date_published":"2026-03-11T07:00:00Z","updated_at":"2026-11-19T08:52:02Z","subjects":["Nanotechnology","Lung Cancer","IONP's Diagnostic Tool","Targeted Delivery","Folic Acid","Cy5 Labeling","Medicinal Chemistry and Pharmaceutics","Nanoscience and Nanotechnology"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://digitalcommons.usf.edu/etd/11412","outbound_label":"Repository record","outbound_source":"dc:identifier","record_url":"https://digitalcommons.usf.edu/etd/11412","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://digitalcommons.usf.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Adigitalcommons.usf.edu%3Aetd-12715","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Diane S. Allen-Gipson, Ph.D.","Mikalai Budzevich, Ph.D.","Ashok Kumar, Ph.D.","Stephanie Zhou, Ph.D."]},{"key":"dc:creator","label":"Author","values":["Secades, Kevin"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2026-03-11T07:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Pharmacy"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Thesis","M.S."]},{"key":"thesis:degree_name","label":"Degree Name","values":["Master of Science (M.S.)"]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["University of South Florida"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Nanotechnology","Lung Cancer","IONP's Diagnostic Tool","Targeted Delivery","Folic Acid","Cy5 Labeling","Medicinal Chemistry and Pharmaceutics","Nanoscience and Nanotechnology"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://digitalcommons.usf.edu/etd/11412"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["Accurate tumor imaging is essential for early cancer detection and treatment monitoring [1]. Technetium-99m (Tc-99m) is a commonly used radioisotope for medical imaging, but its reliance on gamma-ray emission poses challenges related to safety, accessibility, and regulatory constraints[2-5]. This research proposes the development of a dual-modal imaging approach by functionalizing iron-oxide nanoparticles (IONPs) with the fluorescent chromophore Cy5, enabling both MRI contrast enhancement and optical imaging for improved tumor specificity. IONPs provide strong T2-weighted MRI contrast [6], while conjugated near-infrared (NIR) chromophores allow for high-resolution fluorescence imaging [7], making this proposed system adaptable for both in vitro and in vivo applications. Additionally, functionalization with cancer-specific ligands, such as folic acid (FA), enables targeted delivery of the nanoparticle (NP) to tumor cells that overexpress folate receptors (FRs) which are minimally present in healthy tissues [8, 9]. The nanoparticle’s efficacy will be evaluated through in vitro studies with the goal of offering an improved alternative for accurate cancer diagnosis. This multi-modal imaging platform offers a non-radioactive, cost-effective alternative to nuclear medicine tracers, with potential applications in precision cancer diagnostics."]},{"key":"dc:title","label":"Title","values":["Dual-Modal Tumor Imaging Using Functionalized Iron-Oxide Nanoparticles for MRI and Fluorescence"]}]}],"canonical_facts":{"dc:contributor":["Diane S. Allen-Gipson, Ph.D.","Mikalai Budzevich, Ph.D.","Ashok Kumar, Ph.D.","Stephanie Zhou, Ph.D."],"dc:creator":["Secades, Kevin"],"dc:date":["2026-03-11T07:00:00Z"],"dc:description":["Accurate tumor imaging is essential for early cancer detection and treatment monitoring [1]. Technetium-99m (Tc-99m) is a commonly used radioisotope for medical imaging, but its reliance on gamma-ray emission poses challenges related to safety, accessibility, and regulatory constraints[2-5]. This research proposes the development of a dual-modal imaging approach by functionalizing iron-oxide nanoparticles (IONPs) with the fluorescent chromophore Cy5, enabling both MRI contrast enhancement and optical imaging for improved tumor specificity. IONPs provide strong T2-weighted MRI contrast [6], while conjugated near-infrared (NIR) chromophores allow for high-resolution fluorescence imaging [7], making this proposed system adaptable for both in vitro and in vivo applications. Additionally, functionalization with cancer-specific ligands, such as folic acid (FA), enables targeted delivery of the nanoparticle (NP) to tumor cells that overexpress folate receptors (FRs) which are minimally present in healthy tissues [8, 9]. The nanoparticle’s efficacy will be evaluated through in vitro studies with the goal of offering an improved alternative for accurate cancer diagnosis. This multi-modal imaging platform offers a non-radioactive, cost-effective alternative to nuclear medicine tracers, with potential applications in precision cancer diagnostics."],"dc:identifier":["https://digitalcommons.usf.edu/etd/11412"],"dc:subject":["Nanotechnology","Lung Cancer","IONP's Diagnostic Tool","Targeted Delivery","Folic Acid","Cy5 Labeling","Medicinal Chemistry and Pharmaceutics","Nanoscience and Nanotechnology"],"dc:title":["Dual-Modal Tumor Imaging Using Functionalized Iron-Oxide Nanoparticles for MRI and Fluorescence"],"thesis:degree_discipline":["Pharmacy"],"thesis:degree_level":["Thesis","M.S."],"thesis:degree_name":["Master of Science (M.S.)"],"thesis:institution_name":["University of South Florida"]},"updated_at":"2026-11-19T08:52:02Z"}